Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:161 (19 July), doi:10.1136/bmj.327.7407.161-a
| The first 150 words of the full text of this article appear below. |
EDITORCoste et al studied conventional cervical smear testing, monolayer cytology, and human papillomavirus DNA testing for cervical screening, their results being published as the National Institute for Clinical Excellence (NICE) was deciding whether liquid based cytology should be used in the United Kingdom.1 Thus the paper must be interpreted in relation to others with assessment of its relevance to the NHS cervical screening programme.
Coste et al's study is small by cervical screening
standards.2
3 Furthermore, it is a
split sample study with the traditional smear performed in the usual manner
and the monolayer smear performed on residual cells left on the spatula. How
the smears were taken is not clear from the paper or the referred
paper.4 Data show
that this design is faulty, with fewer endocervical cells left for analysis of
the liquid based
cytology,5 as was
also found by Coste et al. Might this design fault
-->
Thomas Ind, consultant gynaecological oncologist
Royal Marsden Hospital, London SW3 6JJ ind@tomind.freeserve.co.uk